Loncar Cancer Immunotherapy Etf Price on December 18, 2024
| CNCR Etf | USD 11.97 0.05 0.42% |
Below is the normalized historical share price chart for Loncar Cancer Immunotherapy extending back to October 14, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Loncar Cancer stands at 11.97, as last reported on the 20th of December, with the highest price reaching 12.14 and the lowest price hitting 11.86 during the day.
If you're considering investing in Loncar Etf, it is important to understand the factors that can impact its price. Loncar Cancer Immuno has Sharpe Ratio of -0.16, which conveys that the entity had a -0.16% return per unit of risk over the last 3 months. Loncar Cancer exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Loncar Cancer's Mean Deviation of 1.64, risk adjusted performance of (0.13), and Standard Deviation of 2.12 to check out the risk estimate we provide.
Loncar Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
3 y Volatility 31.75 | 200 Day MA 14.8199 | 1 y Volatility 37.04 | 50 Day MA 14.4033 | Inception Date 2015-10-13 |
Loncar |
Sharpe Ratio = -0.1645
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNCR |
Estimated Market Risk
| 2.1 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Loncar Cancer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Loncar Cancer by adding Loncar Cancer to a well-diversified portfolio.
Average Mkt Cap Mil 1 K |
Loncar Cancer Valuation on December 18, 2024
It is possible to determine the worth of Loncar Cancer on a given historical date. On December 18, 2024 Loncar was worth 12.62 at the beginning of the trading date compared to the closed value of 12.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Loncar Cancer etf. Still, in general, we apply an absolute valuation method to find Loncar Cancer's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Loncar Cancer where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Loncar Cancer's related companies.
| Open | High | Low | Close | Volume | |
| 12.68 | 12.70 | 12.61 | 12.66 | 1,800 | |
12/18/2024 | 12.62 | 12.63 | 11.95 | 12.02 | 11,547 |
| 12.08 | 12.14 | 11.86 | 11.97 | 5,068 |
| Backtest Loncar Cancer | | | Loncar Cancer History | | | Loncar Cancer Valuation | Previous | Next |
Loncar Cancer Trading Date Momentum on December 18, 2024
| On December 19 2024 Loncar Cancer Immunotherapy was traded for 11.97 at the closing time. The top price for the day was 12.14 and the lowest listed price was 11.86 . The trading volume for the day was 5.1 K. The trading history from December 19, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.42% . The trading delta at closing time against the current closing price is 0.50% . |
Loncar Cancer Immuno Fundamentals Correlations and Trends
By evaluating Loncar Cancer's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Loncar Cancer's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Loncar financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Loncar Cancer Etf history
Loncar Cancer investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Loncar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Loncar Cancer Immuno will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Loncar Cancer stock prices may prove useful in developing a viable investing in Loncar Cancer
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the funds index provider, as having a high strategic focus on the development of drugs that harness the bodys own immune system to fight cancer. Loncar Cancer is traded on NASDAQ Exchange in the United States.
Loncar Cancer Etf Technical Analysis
Loncar Cancer technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
Loncar Cancer Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
Loncar Cancer Immunotherapy cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Loncar Cancer December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Loncar Cancer etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Loncar Cancer shares will generate the highest return on investment. By undertsting and applying Loncar Cancer etf market strength indicators, traders can identify Loncar Cancer Immunotherapy entry and exit signals to maximize returns
Loncar Cancer Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Loncar Cancer's price direction in advance. Along with the technical and fundamental analysis of Loncar Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Loncar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | (0.24) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Loncar Cancer Immunotherapy. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.